About this trial
This study looks at how different treatments for breast cancer affect tumor cells. Researchers want to compare the markers found on these cells before and after chemotherapy. The goal is to identify specific markers that might help predict how well patients respond to treatment and if the cancer might come back later.
The trial ID is NCT00353483. This is an observational study, meaning it looks at outcomes without changing treatment. It is not regulated by the FDA and aims to include about 300 participants.
Who can join
This trial is for adults aged 18 and older, including both men and women. You can join if you have recently been diagnosed with stage II, III, or IV breast cancer and plan to receive certain treatments. You should not be pregnant or have certain infections like Hepatitis or HIV. The trial team will check to confirm if you are eligible to participate.
Condition
Breast Neoplasms
Age group
Adult, Older adult
The study team makes the final call on eligibility.
What happens in the study
Participants will undergo treatments such as chemotherapy. They may have tissue, blood, and bone marrow samples collected at various times during their treatment. This includes samples taken after surgery and possibly later if needed. Everyone will have the chance to receive these treatments and provide samples for study.
Where
This trial is running at 1 location in the United States. It is currently recruiting.
Washington University School of Medicine
St Louis, Missouri